NO20014180L - Anvendelse av fluorinerte triazoler til behandling av smerte og smertefulle lidelser eller oppmerksomhetshunger - Google Patents

Anvendelse av fluorinerte triazoler til behandling av smerte og smertefulle lidelser eller oppmerksomhetshunger

Info

Publication number
NO20014180L
NO20014180L NO20014180A NO20014180A NO20014180L NO 20014180 L NO20014180 L NO 20014180L NO 20014180 A NO20014180 A NO 20014180A NO 20014180 A NO20014180 A NO 20014180A NO 20014180 L NO20014180 L NO 20014180L
Authority
NO
Norway
Prior art keywords
attention
pain
hunger
treatment
painful disorders
Prior art date
Application number
NO20014180A
Other languages
English (en)
Other versions
NO328927B1 (no
NO20014180D0 (no
Inventor
Markus Schmutz
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US09/259,911 external-priority patent/US6054471A/en
Priority claimed from US09/259,910 external-priority patent/US6156775A/en
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of NO20014180L publication Critical patent/NO20014180L/no
Publication of NO20014180D0 publication Critical patent/NO20014180D0/no
Publication of NO328927B1 publication Critical patent/NO328927B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4192—1,2,3-Triazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Neurology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurosurgery (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Epidemiology (AREA)
  • Rheumatology (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
NO20014180A 1999-03-01 2001-08-28 Anvendelse av fluorinerte triazoler til behandling av smerte og smertefulle lidelser NO328927B1 (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US09/259,911 US6054471A (en) 1999-03-01 1999-03-01 Use of fluorinated triazoles in treating neuropathic pain
US09/259,910 US6156775A (en) 1999-03-01 1999-03-01 Use of fluorinated triazoles in treating affective and attention disorders
PCT/EP2000/001626 WO2000051577A2 (en) 1999-03-01 2000-02-28 Use of fluorinated triazoles for treating pain and affective or attention disorders

Publications (3)

Publication Number Publication Date
NO20014180L true NO20014180L (no) 2001-08-28
NO20014180D0 NO20014180D0 (no) 2001-08-28
NO328927B1 NO328927B1 (no) 2010-06-14

Family

ID=26947613

Family Applications (2)

Application Number Title Priority Date Filing Date
NO20014180A NO328927B1 (no) 1999-03-01 2001-08-28 Anvendelse av fluorinerte triazoler til behandling av smerte og smertefulle lidelser
NO20092921A NO334104B1 (no) 1999-03-01 2009-08-31 Anvendelse av fluorinerte triazoler til behandling av affektive forstyrrelser og oppmerksomhetsforstyrrelser.

Family Applications After (1)

Application Number Title Priority Date Filing Date
NO20092921A NO334104B1 (no) 1999-03-01 2009-08-31 Anvendelse av fluorinerte triazoler til behandling av affektive forstyrrelser og oppmerksomhetsforstyrrelser.

Country Status (25)

Country Link
EP (2) EP1156856B1 (no)
JP (1) JP4700195B2 (no)
KR (2) KR100839766B1 (no)
CN (2) CN1636562A (no)
AT (1) ATE303179T1 (no)
AU (1) AU764508B2 (no)
BR (1) BR0008606A (no)
CA (1) CA2362411C (no)
CY (1) CY1115241T1 (no)
DE (1) DE60022317T2 (no)
DK (2) DK1609505T3 (no)
ES (2) ES2441208T3 (no)
HK (1) HK1086775A1 (no)
HU (2) HU227602B1 (no)
ID (1) ID29891A (no)
IL (3) IL144852A0 (no)
NO (2) NO328927B1 (no)
NZ (1) NZ513716A (no)
PL (2) PL197158B1 (no)
PT (1) PT1609505E (no)
RU (1) RU2238725C2 (no)
SI (1) SI1609505T1 (no)
SK (2) SK286775B6 (no)
TW (1) TW513301B (no)
WO (1) WO2000051577A2 (no)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
LT3250563T (lt) 2015-01-30 2022-04-11 Neurocrine Biosciences, Inc. Pakeisti triazolai ir su jais susiję būdai

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1511195A (en) * 1976-10-18 1978-05-17 Ici America Inc Triazole derivatives
PH22568A (en) * 1985-04-18 1988-10-17 Ciba Geigy Ag Fluorinated benzyl triazoles and pharmaceutical compositions containing the same

Also Published As

Publication number Publication date
PL199660B1 (pl) 2008-10-31
CA2362411A1 (en) 2000-09-08
TW513301B (en) 2002-12-11
EP1156856B1 (en) 2005-08-31
NO20092921L (no) 2001-08-28
WO2000051577A3 (en) 2001-01-25
IL144852A (en) 2008-11-26
CN1356916A (zh) 2002-07-03
HUP0302780A2 (hu) 2003-12-29
KR20080003944A (ko) 2008-01-08
KR100839765B1 (ko) 2008-06-20
SK286203B6 (sk) 2008-05-06
RU2238725C2 (ru) 2004-10-27
PL350418A1 (en) 2002-12-16
EP1156856A2 (en) 2001-11-28
EP1609505B1 (en) 2013-12-11
NO328927B1 (no) 2010-06-14
SK286775B6 (sk) 2009-05-07
CN1636562A (zh) 2005-07-13
IL144852A0 (en) 2002-06-30
HU230044B1 (hu) 2015-05-28
JP4700195B2 (ja) 2011-06-15
NO334104B1 (no) 2013-12-09
HK1086775A1 (en) 2006-09-29
SI1609505T1 (sl) 2014-03-31
IL189190A0 (en) 2008-06-05
BR0008606A (pt) 2002-01-22
KR20010108285A (ko) 2001-12-07
WO2000051577A2 (en) 2000-09-08
PL197158B1 (pl) 2008-03-31
ES2244413T3 (es) 2005-12-16
HU1000576D0 (en) 2010-12-28
SK12252001A3 (sk) 2002-05-09
AU3425300A (en) 2000-09-21
ATE303179T1 (de) 2005-09-15
EP1609505A1 (en) 2005-12-28
DK1609505T3 (en) 2014-02-17
PT1609505E (pt) 2014-02-24
DE60022317D1 (de) 2005-10-06
KR100839766B1 (ko) 2008-06-20
ES2441208T3 (es) 2014-02-03
JP2002538100A (ja) 2002-11-12
HU227602B1 (en) 2011-09-28
CY1115241T1 (el) 2017-01-04
CA2362411C (en) 2009-11-24
CN1195516C (zh) 2005-04-06
NO20014180D0 (no) 2001-08-28
ID29891A (id) 2001-10-18
NZ513716A (en) 2003-10-31
HUP0302780A3 (en) 2004-10-28
DK1156856T3 (da) 2005-10-31
AU764508B2 (en) 2003-08-21
DE60022317T2 (de) 2006-06-01

Similar Documents

Publication Publication Date Title
ATE501722T1 (de) Therapeutische behandlung androgenrezeptorbedingter leiden
DE69213814T2 (de) Melatoninderivate zur Behandlung von Schlafstörungen und zur Pre-Anästhesie
DE69403969T2 (de) Levobupivacain nützlich zur behandlung von chronischen schmerzen
DE69703689T2 (de) Therapeutische anwendungen von bpi-protein-produkten zur behandlung von humaner meningococcämia
ATE214272T1 (de) Topische verwendung von kappa- opioidrezeptoragonisten zur behandlung von augenschmerz
DE69902520D1 (de) Verwendung von selegilin oder desmethylselegilin zur behandlung von wunden, verbrennungen und hautschäden
NO20014180L (no) Anvendelse av fluorinerte triazoler til behandling av smerte og smertefulle lidelser eller oppmerksomhetshunger
NO20041955L (no) Monohydroksylkarbamazepin for anvendelse ved fremstillingen av et medikament for affektive lidelser eller oppmerksomhetsforstyrrelser og neuropatisk smerte
ATE302009T1 (de) Ubichinon qn zur behandlung von migräneschmerzen
DE69900774D1 (de) Verwendung von topische präparationen mit glyceryl trinitrat und lanolin zur behandlung von erektilen funktionsstörungen
ATE369143T1 (de) Verwendung von ngali nussöl zur behandlung/linderung der arthritisschmerzen und anderer ähnlichen störungen
ATE216884T1 (de) Verwendung von sulbutiamin zur behandlung von psychomotorischen oder psychointellektuellen beschwerden
ATE288263T1 (de) Verwendung von n-oleoylethanolamin zur behandlung der schuppenflechte (psoriasis)
DE69831336D1 (de) Tazaroten und uvb-phototherapie zur behandlung von psoriasis
ZA200107138B (en) Use of fluorinated triazoles for treating pain and affective or attention disorders.
DE29803925U1 (de) Radial-Belüfter zur Behandlung von Wunden und Hauterkrankungen
UA29506C2 (uk) Лікувально-косметичний засіб "фіто-пелоїд"
UA36485A (uk) Спосіб лікування генералізованого пародонтиту

Legal Events

Date Code Title Description
MK1K Patent expired